Session

PP 05 IBD (Posters)

IMPROVEMENT IN INFLAMMATORY BIOMARKER LEVELS THROUGH WEEK 12 IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS PATIENTS TREATED WITH GUSELKUMAB: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
IMPROVEMENT IN INFLAMMATORY BIOMARKER LEVELS THROUGH WEEK 12 IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS PATIENTS TREATED WITH GUSELKUMAB: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

TOFACITINIB RELATED CANCER RISK: RESULTS FROM A SYSTEMATIC REVIEW WITH META-ANALYSIS
TOFACITINIB RELATED CANCER RISK: RESULTS FROM A SYSTEMATIC REVIEW WITH META-ANALYSIS

NEW INSIGHTS INTO THE MECHANISM OF ACTION OF GRANULOCYTE-MONOCYTE APHERESIS REVEALED BY SINGLE-CELL TRANSCRIPTOMIC ANALYSIS
NEW INSIGHTS INTO THE MECHANISM OF ACTION OF GRANULOCYTE-MONOCYTE APHERESIS REVEALED BY SINGLE-CELL TRANSCRIPTOMIC ANALYSIS

PREVALENCE OF MULTIPLE SCLEROSIS IS NOT HIGHER IN INFLAMMATORY BOWEL DISEASE POPULATION: A CASE CONTROL STUDY
PREVALENCE OF MULTIPLE SCLEROSIS IS NOT HIGHER IN INFLAMMATORY BOWEL DISEASE POPULATION: A CASE CONTROL STUDY

REINITIATION OF OZANIMOD AFTER DOSE INTERRUPTION: ASSESSMENT OF EFFECT ON HEART RATE
REINITIATION OF OZANIMOD AFTER DOSE INTERRUPTION: ASSESSMENT OF EFFECT ON HEART RATE

PREGNANCY OUTCOMES IN THE OZANIMOD CLINICAL DEVELOPMENT PROGRAM IN ULCERATIVE COLITIS, CROHN’S DISEASE, AND RELAPSING MULTIPLE SCLEROSIS
PREGNANCY OUTCOMES IN THE OZANIMOD CLINICAL DEVELOPMENT PROGRAM IN ULCERATIVE COLITIS, CROHN’S DISEASE, AND RELAPSING MULTIPLE SCLEROSIS

ANTI-INFLAMMATORY EFFECT OF MAQUI EXTRACT ON PPAR-Α EXPRESSION IN EPITHELIAL AND MACROPHAGE CELLS IN COLON TISSUE FROM EXPERIMENTAL MODEL OF CROHN’S DISEASE
ANTI-INFLAMMATORY EFFECT OF MAQUI EXTRACT ON PPAR-Α EXPRESSION IN EPITHELIAL AND MACROPHAGE CELLS IN COLON TISSUE FROM EXPERIMENTAL MODEL OF CROHN’S DISEASE

TARGETING IMPROVED TREG SELECTIVITY WITH THE IL-2 MUTEIN EFAVALEUKIN ALFA: RATIONALE FOR IL-2 THERAPY IN ULCERATIVE COLITIS
TARGETING IMPROVED TREG SELECTIVITY WITH THE IL-2 MUTEIN EFAVALEUKIN ALFA: RATIONALE FOR IL-2 THERAPY IN ULCERATIVE COLITIS

THE LONG-TERM EFFECT ON SURGERY-FREE SURVIVAL OF BIOLOGICAL COMPARED TO CONVENTIONAL THERAPY IN CROHN’S DISEASE IN REAL WORLD-DATA: A PROPENSITY-SCORE MATCHED STUDY
THE LONG-TERM EFFECT ON SURGERY-FREE SURVIVAL OF BIOLOGICAL COMPARED TO CONVENTIONAL THERAPY IN CROHN’S DISEASE IN REAL WORLD-DATA: A PROPENSITY-SCORE MATCHED STUDY

CELL WALL DEFICIENT (CWD) MYCOBACTERIA IN WBCS AND ILEAL CROHN’S TISSUES
CELL WALL DEFICIENT (CWD) MYCOBACTERIA IN WBCS AND ILEAL CROHN’S TISSUES

THE PROBIOTIC SACCHAROMYCES BOULARDII CNCM I-745 PRESERVES AND RESTORES THE FUNCTIONALITY OF THE INTESTINAL BRUSH BORDER UPON INFLAMMATION
THE PROBIOTIC SACCHAROMYCES BOULARDII CNCM I-745 PRESERVES AND RESTORES THE FUNCTIONALITY OF THE INTESTINAL BRUSH BORDER UPON INFLAMMATION

CLINICAL FACTORS ASSOCIATED WITH NAFLD IN IBD PATIENTS AND COMPARISON BETWEEN PATIENTS WITH NAFLD EXCLUSIVELY
CLINICAL FACTORS ASSOCIATED WITH NAFLD IN IBD PATIENTS AND COMPARISON BETWEEN PATIENTS WITH NAFLD EXCLUSIVELY

INCIDENCE, EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
INCIDENCE, EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

DECLINING TRENDS OF REOPERATIONS AND DISEASE BEHAVIOR PROGRESSION BUT NOT FIRST RESECTIVE SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A PROSPECTIVE POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COHO
DECLINING TRENDS OF REOPERATIONS AND DISEASE BEHAVIOR PROGRESSION BUT NOT FIRST RESECTIVE SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A PROSPECTIVE POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COHO

PLATELET ACTIVATION AND PLATELET-MONOCYTE INTERACTIONS CORRELATE WITH MUCOSAL INFLAMMATION AND DISEASE SEVERITY IN ULCERATIVE COLITIS
PLATELET ACTIVATION AND PLATELET-MONOCYTE INTERACTIONS CORRELATE WITH MUCOSAL INFLAMMATION AND DISEASE SEVERITY IN ULCERATIVE COLITIS

BURDEN OF PERIANAL DISEASE AND PERIANAL SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
BURDEN OF PERIANAL DISEASE AND PERIANAL SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

AN INDIRECT COMPARISON OF ADALIMUMAB AND AZATHIOPRINE IN THE MANAGEMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER REAL WORLD STUDY
AN INDIRECT COMPARISON OF ADALIMUMAB AND AZATHIOPRINE IN THE MANAGEMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER REAL WORLD STUDY

TOFACITINIB IN ULCERATIVE COLITIS: THE RELATIONSHIP BETWEEN OCTAVE INDUCTION WEEK 8 SYMPTOMATIC REMISSION AND OCTAVE SUSTAIN WEEK 52 REMISSION
TOFACITINIB IN ULCERATIVE COLITIS: THE RELATIONSHIP BETWEEN OCTAVE INDUCTION WEEK 8 SYMPTOMATIC REMISSION AND OCTAVE SUSTAIN WEEK 52 REMISSION

TREATMENT DISCONTINUATION FOR BIOSIMILAR VERSUS ORIGINATOR IN INFLIXIMAB INITIATORS
TREATMENT DISCONTINUATION FOR BIOSIMILAR VERSUS ORIGINATOR IN INFLIXIMAB INITIATORS

SMALL INTESTINAL CONTRAST ULTRASONOGRAPHY (SICUS) IN CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
SMALL INTESTINAL CONTRAST ULTRASONOGRAPHY (SICUS) IN CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS

Item 781 - 800 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39
40
41 42